Actualités et Activités de Full-Life Technologies
Dirigeants
Voir l'organigramme avec ses 17 principaux dirigeants
Biographies les plus recherchées chez Full-Life Technologies
- Lanny Sun, Co-Founder, Chairman and Chief Executive Officer
- Edward Myles, Director
- Philippe Van Put, General Manager, Europe
Changements de dirigeants chez Full-Life Technologies
- Edward Myles, a rejoint l'entreprise comme Director (publié le 22 juillet 2024).
Créer une alerte
pour suivre les mouvements de dirigeants chez Full-Life Technologies.
Équipements médicaux
Full-Life Technologies a 1 020 concurrents dont Philips (Pays—Bas), Medtronic (Irlande) et Thermo Fisher Scientific (Etats—Unis).
Actualités en fusion/acquisition en Équipements médicaux.
- Globus Medical has announced the acquisition of Nevro (publié le 4 avril 2025).
- Amboss vient d'annoncer une levée de fonds de 259 millions de dollars. (publié le 3 avril 2025).
- Patricia Industries has announced the acquisition of Nova Biomedical (publié le 24 mars 2025).
Contacts en Équipements médicaux
Actualités
Derniers communiqués de presse par Full-Life Technologies
- Full-Life Technologies to Participate in the 43rd Annual J.P. Morgan Healthcare Conference-Press Releases-From Half-Life to Full-Life.Full-Life Technologies to Participate in the 43rd Annual J.P. Morgan Healthcare Conference-Press Releases-From Half-Life
- Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releas
- Full-Life Technologies to Present Three Top Rated Oral Presentations at the 37th Annual Congress of the European Association of Nuclear Medicine-Press Releases-From Half-Life to Full-Life.Full-Life Technologies to Present Three Top Rated Oral Presentation
- Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-Fro
- Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Ther
- Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-
- Press Releases-From Half-Life to Full-Life.Press Releases-From Half-Life to Full-Life.
- Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces Clearance from FDA of
- Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Disclosed Preclinical Data of its NTSR1-
- Full-Life Technologies will showcase preclinical data of its NTSR1-targeted RDC program FL-091 in an oral presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies will showcase preclinical data of its
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Full-Life Technologies
- Full-Life Technologies sur Wikipédia, Google News & Yahoo Finance en 1-click
- Full-Life Technologies sur LinkedIn, Twitter & YouTube en 1-click
